Tata Chemicals Limited
Our verdict
Valuation (86/100) does the heavy lifting; financial trend (20/100) is the drag.
Our fair value
Undervalued by 28%Buy-below (20% margin of safety): ₹666.95
Our blended model reads Tata Chemicals Limited as a Sell at 40/100. At ₹650.05 it trades below our blended DCF and relative-multiples fair value of ₹833.69, about 28% upside to that estimate — we read it as undervalued by 28%. On 21.6x trailing earnings it sits roughly in line with the Basic Materials median of about 22.2x. The price is about 19% below its 52-week high of ₹806.5 and 13% above the low of ₹574.42. Financial health scores 8/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 2/9. The average analyst target of ₹721.78 implies about 11% upside across 9 analysts. It clears 4 of 12 investability checks, with durability 20, valuation 74 and momentum 46 on our 0–100 scales.
Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹666.95.
Analyst views
1-year price
EOD · 2026-11-2052-week range
-19.40% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 2/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: -7.7%
- Pass: Low debt (D/E < 0.5): 0.36x
- Fail: Positive free cash flow
- Fail: Revenue growth > 10%: -2%
- No data: Earnings growing
- Fail: Net margin ≥ 10%: -13.0%
- Fail: Current ratio > 1.5: 1.07
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 1.31
- Fail: Piotroski ≥ 7: 2/9
Quarterly results
Annual financials
Shareholding
- Promoter38.7%
- Institutions28.4%
- Public & other32.9%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
Opportunities
- Trading in our value buy zone versus sector peers.
- Trades ~28% below our estimated fair value.
Bear case
Weaknesses
- Low return on equity (-7.7%).
- Price below its 200-day moving average (downtrend).
- Weak Piotroski score (2/9).
Threats
- Balance-sheet stress — Altman Z 1.31.
About Tata Chemicals Limited
Tata Chemicals Limited, together with its subsidiaries, manufactures, markets, sells, and distributes basic chemistry and specialty products in India, rest of Asia, Africa, Europe, the United Kingdom, the Americas, and internationally. The company offers dense, heavy, high purity, industrial grade, and light soda ash; allied chemicals, such as caustic soda, chlorine and bromine-based products, and gypsum; sodium bicarbonate; sodium chloride; calcium chloride; crushed refined
Tata Chemicals Limited — frequently asked questions
Is Tata Chemicals Limited a buy, hold or sell?
TickerMagic currently rates Tata Chemicals Limited (TATACHEM) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Tata Chemicals Limited's fair value?
Our blended DCF and relative-valuation model estimates Tata Chemicals Limited's fair value at about ₹833.69, versus a current price of ₹650.05 — roughly 28% upside. On that basis the stock looks undervalued by 28%.
Is Tata Chemicals Limited financially healthy?
Tata Chemicals Limited scores 8/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 2/9.
How has Tata Chemicals Limited's share price performed?
Tata Chemicals Limited is roughly flat over three months, and last traded at ₹650.05. Past performance doesn't predict future returns.
More in Basic Materials
Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.